Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-16-089676
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-13 17:05:38
Reporting Period:
2016-01-11
Filing Date:
2016-01-13
Accepted Time:
2016-01-13 17:05:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410939 Ophthotech Corp. OPHT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1252522 Nicholas Galakatos C/o Clarus Ventures, Llc
101 Main Street, Suite 1210
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-01-11 999 $65.45 6,685 No 4 S Direct
Common Stock Disposition 2016-01-11 1,001 $66.33 5,684 No 4 S Direct
Common Stock Disposition 2016-01-11 501 $65.45 4,444 No 4 S Indirect See Footnote
Common Stock Disposition 2016-01-11 499 $65.33 3,945 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2015.
  2. The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by AAG Peakham LLC on September 10, 2015.
  3. Shares are held by AAG Peakham LLC of which the Reporting Person is a manager.
  4. These shares were disposed of in multiple transactions on January 11, 2016 at actual sales prices ranging from $65.00 to $65.78 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. These shares were disposed of in multiple transactions on January 11, 2016 at actual sales prices ranging from $66.11 to $66.51 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. These shares were disposed of in multiple transactions on January 11, 2016 at actual sales prices ranging from $65.00 to $65.78 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. These shares were disposed of in multiple transactions on January 11, 2016 at actual sales prices ranging from $66.11 to $66.51 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.